Marker Therapeutics, Inc. financial data

Symbol
MRKR on Nasdaq
Location
Houston, TX
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 13, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 556 % +11.7%
Debt-to-equity 21.9 % -12.7%
Return On Equity -92.4 % -2.36%
Return On Assets -75.7 % -5.05%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 16.7M shares +86.8%
Common Stock, Shares, Outstanding 16.7M shares +87.6%
Entity Public Float 48.5M USD +110%
Common Stock, Value, Issued 16.7K USD +86.8%
Weighted Average Number of Shares Outstanding, Basic 16.8M shares +87.8%
Weighted Average Number of Shares Outstanding, Diluted 16.8M shares +87.8%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 14.7M USD +34.1%
General and Administrative Expense 4.37M USD -4.93%
Operating Income (Loss) -14.9M USD -45.8%
Net Income (Loss) Attributable to Parent -14.3M USD -47.5%
Earnings Per Share, Basic -1 USD/shares -10.9%
Earnings Per Share, Diluted -1 USD/shares -10.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 17.6M USD +95.5%
Assets, Current 21.7M USD +99.2%
Property, Plant and Equipment, Net 11.7M USD -18.5%
Operating Lease, Right-of-Use Asset 5.33M USD -44.4%
Assets 21.7M USD +99.2%
Accounts Payable, Current 951K USD -50.1%
Employee-related Liabilities, Current 49K USD +25.6%
Liabilities, Current 3.35M USD -3.32%
Operating Lease, Liability, Noncurrent 6.82M USD -38.2%
Liabilities 3.35M USD -3.32%
Retained Earnings (Accumulated Deficit) -457M USD -3.23%
Stockholders' Equity Attributable to Parent 18.4M USD +147%
Liabilities and Equity 21.7M USD +99.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -5.5M USD -43.3%
Net Cash Provided by (Used in) Financing Activities 49.1K USD -92.1%
Net Cash Provided by (Used in) Investing Activities -113K USD +95.4%
Common Stock, Shares Authorized 30M shares 0%
Common Stock, Shares, Issued 16.7M shares +87.6%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 18.9M USD +110%
Deferred Tax Assets, Valuation Allowance 41M USD +3.24%
Deferred Tax Assets, Gross 41M USD +3.24%
Operating Lease, Liability 7.49M USD -36.1%
Depreciation 800K USD -63.6%
Lessee, Operating Lease, Liability, to be Paid 9.23M USD -38.4%
Property, Plant and Equipment, Gross 17.8M USD +30.9%
Operating Lease, Liability, Current 665K USD -2.76%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.29M USD -16.3%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.25M USD +30.5%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.74M USD -46.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.18M USD -35.5%
Deferred Tax Assets, Operating Loss Carryforwards 30.7M USD +4.68%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.16M USD -37.9%
Operating Lease, Payments 232K USD -26.6%
Additional Paid in Capital 476M USD +5.6%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 818K USD +42%
Share-based Payment Arrangement, Expense 477K USD +41.5%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%